- Exchange: -
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
NeurogesX Inc
I8Z:GR
Ticker Delisted
Snapshot for NeurogesX Inc (I8Z)
| Open: | - | Day's Range: | - | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | - | 52wk Range: | 0.112 - 0.284 | 1-Yr Rtn: | - |
Key Statistics for I8Z
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2012) | - |
| Relative P/E vs. DAX | - |
| Earnings Per Share (ttm) | - |
| Est. EPS (12/2012) | - |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 0 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 05/24/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for I8Z
Company Profile & Key Executives for I8Z
NeurogesX, Inc. is a biopharmaceutical company. The Company develops treatments for chronic peripheral neuropathic pain including postherpetic neuralgia, painful HIV-distal sensory polyneuropathy, and painful diabetic neuropathy.
| Gary A LyonsChairman | Ronald A MartellPresident/CEO |
| Stephen F GhiglieriExec VP/CFO/COO/Secretary | Stephen J PeroutkaExec VP/Chief Medical Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
I8Z News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page